Home > PE Ratio > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of BALAXI PHARMACEUTICALS is 13.91.

Share Price ₹23.8Apr 10,2026
Market Cap ₹131.3 Cr
Earnings-TTM₹9.4 CrTTM-Consolidated Results
Price/Earnings13.91xCalculated as Market Cap/Earnings
Explore Stock Analytics
AD     Remove this Ad
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BALAXI PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹131.3 Cr] as on Apr 10,2026

(/) Earnings [ ₹9.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 13.91x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 13.91 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS


PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS

- BALAXI PHARMACEUTICALS 's latest p/e ratio is 13.91x.

- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.25x.

- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.

- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BALAXI PHARMACEUTICALS 9.4413.91131.3
ADANI ENTERPRISES LTD13,793.0019.57269,938.0
REDINGTON LTD1,914.319.0217,273.3
MMTC LTD180.6949.128,875.5
HONASA CONSUMER LTD155.7572.0211,217.1
LLOYDS ENTERPRISES LTD341.4526.529,055.5
ENTERO HEALTHCARE SOLUTIONS LTD132.1339.415,207.4
OPTIEMUS INFRACOM LTD65.7751.273,372.0
POLO QUEEN INDUSTRIAL & FINTECH LTD2.82264.81745.7
MSTC LTD223.0213.352,977.9
SG MART LTD102.7366.236,804.0

Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 9.02x
Max industry PE 264.81x
Median industry PE 39.41x
Average industry PE 56.84x



You may also like the below Video Courses